A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption

Clinical Journal of Pain

Volumn 32, Issue 4, 2016, Pages 327-336

  Boakye, Paul A ^a   Olechowski, Camille ^b   Rashiq, Saifudin ^b   Verrier, Michelle J ^b   Kerr, Bradley ^b   Witmans, Manisha ^c   Baker, Glen ^d   Joyce, Anthony ^d   Dick, Bruce D ^a,b,d  

^a Centre for Neuroscience   (United States)

^b Department of Anesthesiology and Pain Medicine ^*  (United States)

^c School of Dentistry   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic pain; Depression; Neurobiology; Sleep disruption

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; NEUROTRANSMITTER; SEROTONIN;

BLOOD LEVEL; CHRONIC PAIN; CLINICAL TRIAL (TOPIC); DEPRESSION; DOWN REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROBIOLOGY; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER; COMORBIDITY; DEPRESSIVE DISORDER; METABOLISM; SLEEP WAKE DISORDERS;

CHRONIC PAIN; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; NEUROBIOLOGY; SLEEP WAKE DISORDERS;

EID: 84962576449     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000260     Document Type: Review

References (78)

1. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull. 2001;35:5-49.
2. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuro-sci Biobehav Rev. 2007;31:858-873.
3. Xu H, Qing H, Lu W, et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neuro-trophic factor expression in rat hippocampus. Neurosci Lett. 2002;321:65-68.
4. Woolf CJ, Wall PD. Chronic peripheral nerve section diminishes the primary afferent A-fibre mediated inhibition of rat dorsal horn neurones. Brain Res. 1982;242:77-85.
5. Lentjes EG, Griep EN, Boersma JW, et al. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendoc-rinology. 1997;22:603-614.
6. Amir R, Michaelis M, Devor M. Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain. J Neurosci. 1999;19:8589-8596.
7. Widmer RB, Cadoret RJ. Depression in primary care: changes in pattern of patient visits and complaints during a developing depression. J Fam Pract. 1978;7:293-302.
8. Widmer RB, Cadoret RJ. Depression in family practice: changes in pattern of patient visits and complaints during subsequent developing depressions. J Fam Pract. 1979;9:1017-1021.
9. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol. 2001;13:1009-1023.
10. Von Korff M, Dworkin SF, Le Resche L, et al. An epidemiologic comparison of pain complaints. Pain. 1988;32:173-183.
11. Biggs JE, Lu VB, Stebbing MJ, et al. Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol Pain. 2010;6:44.
12. Delgado PL. Common pathways of depression and pain. J Clin Psychiatry. 2004;65(suppl 12):16-19.
13. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361-1368.
14. Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychosom Med. 2004;66:17-22.
15. Born J, Kern W, Bieber K, et al. Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry. 1986;21:1415-1424.
16. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10:206-219.
17. Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438:1017-1021.
18. Holsboer F, Lauer CJ, Schreiber W, et al. Altered hypothala-mic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology. 1995;62:340-347.
19. Taylor BK, Akana SF, Peterson MA, et al. Pituitary-adrenocort-ical responses to persistent noxious stimuli in the awake rat: endogenous corticosterone does not reduce nociception in the formalin test. Endocrinology. 1998;139:2407-2413.
20. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur Psychiatry. 2002;17(suppl 3):294-299.
21. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477-501.
22. Haythornthwaite JA, Hegel MT, Kerns RD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage. 1991;6:65-72.
23. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ. 2001;65:1378-1382.
24. Barad MJ, Ueno T, Younger J, et al. Complex regional pain syndrome is associated with structural abnormalities in pain-related regions of the human brain. J Pain. 2014;15:197-203.
25. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology. 2005;65:1483-1486.
26. Schweinhardt P, Bushnell MC. Pain imaging in health and disease-how far have we come? J Clin Invest. 2010;120:3788-3797.
27. Steiger A, Holsboer F. Neuropeptides and human sleep. Sleep. 1997;20:1038-1052.
28. Mayer EA, Berman S, Suyenobu B, et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain. 2005; 115:398-409.
29. Strigo IA, Simmons AN, Matthews SC, et al. Association of major depressive disorder with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry. 2008;65:1275-1284.
30. Riemann D, Voderholzer U, Spiegelhalder K, et al. Chronic insomnia and MRI-measured hippocampal volumes: a pilot study. Sleep. 2007;30:955-958.
31. Spiegelhalder K, Regen W, Baglioni C, et al. Neuroimaging studies in insomnia. Curr Psychiatry Rep. 2013;15:405.
32. Spiegelhalder K, Regen W, Baglioni C, et al. Insomnia does not appear to be associated with substantial structural brain changes. Sleep. 2013;36:731-737.
33. Watson S, Owen BM, Gallagher P, et al. Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders. Neuro-psychiatr Dis Treat. 2007;3:647-653.
34. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284:592-597.
35. Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendocrinology. 2009;34:1272-1283.
36. Spath-Schwalbe E, Gofferje M, Kern W, et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry. 1991;29:575-584.
37. Koella WP. Neurohumoral aspects of sleep control. Biol Psychiatry. 1969;1:161-177.
38. Anacker C, Zunszain PA, Carvalho LA, et al. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology. 2011;36:415-425.
39. Sinclair D, Tsai SY, Woon HG, et al. Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness. Neuropsychopharmacol-ogy. 2011;36:2698-2709.
40. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry. 1997;54:597-606.
41. Aloisi AM, Albonetti ME, Muscettola M, et al. Effects of formalin-induced pain on ACTH, beta-endorphin, cortico-sterone and interleukin-6 plasma levels in rats. Neuroendocri-nology. 1995;62:13-18.
42. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6:521-532.
43. Mor D, Keay KA. Differential regulation of glucocorticoid receptor expression in distinct columns of periaqueductal grey in rats with behavioural disability following nerve injury. Cell Mol Neurobiol. 2013;33:953-963.
44. Weitzman ED, Zimmerman JC, Czeisler CA, et al. Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab. 1983;56:352-358.
45. Challa SR. Surgical animal models of neuropathic pain: pros and cons. Int J Neurosci. 2014;125:170-174.
46. Ramer MS, Kawaja MD, Henderson JT, et al. Glial over-expression of NGF enhances neuropathic pain and adrenergic sprouting into DRG following chronic sciatic constriction in mice. Neurosci Lett. 1998;251:53-56.
47. Ulmann L, Hatcher JP, Hughes JP, et al. Up-regulation of P2x4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci. 2008;28:11263-11268.
48. DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 1997;759:50-57.
49. Mosconi T, Kruger L. Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations. Pain. 1996;64:37-57.
50. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895-926.
51. Lu VB, Biggs JE, Stebbing MJ, et al. Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol. 2009;587:1013-1032.
52. Duric V, McCarson KE. Effects of analgesic or antidepressant drugs on pain-or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. J Pharmacol Exp Ther. 2006;319:1235-1243.
53. Altar CA. Neurotrophins and depression. Trends Pharmacol Sci. 1999;20:59-61.
54. Russo-Neustadt A, Ha T, Ramirez R, et al. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res. 2001;120:87-95.
55. Garcia LS, Comim CM, Valvassori SS, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:140-144.
56. Gao S, Cui YL, Yu CQ, et al. Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor. Behav Brain Res. 2013;238:79-85.
57. Chen B, Dowlatshahi D, MacQueen GM, et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50:260-265.
58. Kushikata T, Fang J, Krueger JM. Brain-derived neurotrophic factor enhances spontaneous sleep in rats and rabbits. Am J Physiol. 1999;276:R1334-R1338.
59. Wallingford JK, Deurveilher S, Currie RW, et al. Increases in mature brain-derived neurotrophic factor protein in the frontal cortex and basal forebrain during chronic sleep restriction in rats: possible role in initiating allostatic adaptation. Neuro-science. 2014;277C:174-183.
60. Martinowich K, Schloesser RJ, Jimenez DV, et al. Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior. Mol Brain. 2011;4:11.
61. Fujihara H, Sei H, Morita Y, et al. Short-term sleep disturbance enhances brain-derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor. J Mol Neurosci. 2003;21:223-232.
62. Giese M, Unternahrer E, Huttig H, et al. BDNF: an indicator of insomnia? Mol Psychiatry. 2014;19:151-152.
63. Wolf G, Gabay E, Tal M, et al. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain. 2006;120:315-324.
64. Nadeau S, Filali M, Zhang J, et al. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1beta and TNF: implications for neuropathic pain. J Neurosci. 2011;31:12533-12542.
65. Geiss A, Rohleder N, Anton F. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyal-gia. Psychoneuroendocrinology. 2012;37:671-684.
66. Arruda JL, Colburn RW, Rickman AJ, et al. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Brain Res Mol Brain Res. 1998;62:228-235.
67. Lotrich F. Inflammatory cytokines, growth factors, and depression. Curr Pharm Des. 2012;18:5920-5935.
68. Shintani F. Cytokines and neurotrophins in psychiatric disorders. Biomed Rev. 1999;10:69-73.
69. Alam MN, McGinty D, Bashir T, et al. Interleukin-1beta modulates state-dependent discharge activity of preoptic area and basal forebrain neurons: role in sleep regulation. Eur J Neurosci. 2004;20:207-216.
70. Kapsimalis F, Richardson G, Opp MR, et al. Cytokines and normal sleep. Curr Opin Pulm Med. 2005;11:481-484.
71. Krueger JM, Obal FJ, Fang J, et al. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001;933:211-221.
72. Moldofsky H, Lue FA, Eisen J, et al. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med. 1986;48:309-318.
73. Jewett KA, Krueger JM. Humoral sleep regulation; interleukin-1 and tumor necrosis factor. Vitam Horm. 2012;89:241-257.
74. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66:355-474.
75. Chiu YH, Silman AJ, Macfarlane GJ, et al. Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain. 2005; 115:316-321.
76. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31:464-468.
77. Wagner U, Born J. Memory consolidation during sleep: interactive effects of sleep stages and HPA regulation review. Stress. 2008;11:28-41.
78. Aloisi AM, Buonocore M, Merlo L, et al. Chronic pain therapy and hypothalamic-pituitart-adrenal axis impairment. Psychoneuroendocrinology. 2011;36:1032-1039.